Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis

References

• Guiducci S, Distler O., Distler J. H., Matucci-Cerinic M.. Mechanisms of vascular damage in SSc–implications for vascular treatment strategies. Rheumatology (Oxford). 2008; 47 Suppl 5: v18–v20.
   Google Scholar
• Pattanaik D, Brown M., Postlethwaite A. E.. Vascular involvement in systemic sclerosis (scleroderma). J. Inflamm. Res. 2012; 4:105–125.
   Google Scholar
• Gabrielli A., Avvedimento E. V., Krieg T.. Scleroderma. N. Engl. J. Med. 2009; 360:1989–2003.
   PubMed Web of Science ®Google Scholar
• Ho-Tin-Noe B., Demers M., Wagner D. D.. How platelets safeguard vascular integrity. J. Thromb. Haemost. 2011; 9 Suppl 1: 56–65.
   PubMed Web of Science ®Google Scholar
• Postlethwaite A. E., Chiang T. M.. Platelet contributions to the pathogenesis of systemic sclerosis. Curr. Opin. Rheumatol. 2007; 19:574–579.
   PubMed Web of Science ®Google Scholar
• Maugeri N., Baldini M., Rovere-Querini P., Maseri A., Sabbadini M. G., Manfredi A. A.. Leukocyte and platelet activation in patients with giant cell arteritis and polymyalgia rheumatica: a clue to thromboembolic risks?. Autoimmunity. 2009; 42:386–388.
   PubMed Web of Science ®Google Scholar
• Maugeri N., Rovere-Querini P., Evangelista V., Covino C., Capobianco A., Bertilaccio M. T., Piccoli A., Totani L., Cianflone D., Maseri A., Manfredi A. A.. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program. Blood. 2009; 113:5254–5265.
   PubMed Web of Science ®Google Scholar
• Semple J. W., Italiano J. E.Jr, Freedman J.. Platelets and the immune continuum. Nat. Rev. Immunol. 2011; 11:264–274.
   PubMed Web of Science ®Google Scholar
• Maugeri N., Malato S., Femia E. A., Pugliano M., Campana L., Lunghi F., Rovere-Querini P., Lussana F., Podda G., Cattaneo M., Ciceri F., Manfredi A. A.. Clearance of circulating activated platelets in Polycythemia vera and essential thrombocythemia. Blood. 2011; 118:3359–3366.
   PubMedGoogle Scholar
• Maugeri N., Baldini M., Ramirez G. A., Rovere-Querini P., Manfredi A. A.. Platelet-leukocyte deregulated interactions foster sterile inflammation and tissue damage in immune-mediated vessel diseases. Thromb. Res. 2012; 129:267–273.
   PubMed Web of Science ®Google Scholar
• Rovere-Querini P., Castiglioni M. T., Sabbadini M. G., Manfredi A. A.. Signals of cell death and tissue turnover during physiological pregnancy, pre-eclampsia, and autoimmunity. Autoimmunity. 2007; 40:290–294.
   PubMed Web of Science ®Google Scholar
• Cerinic M. M., Valentini G., Sorano G. G., D'Angelo S., Cuomo G., Fenu L., Generini S., Cinotti S., Morfini M., Pignone A., Guiducci S., Del Rosso A., Kalfin R., Das D., Marongiu F.. Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. Semin. Arthritis Rheum. 2003; 32:285–295.
   PubMed Web of Science ®Google Scholar
• Rouhiainen A., Imai S., Rauvala H., Parkkinen J.. Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb. Haemost. 2000; 84:1087–1094.
   PubMed Web of Science ®Google Scholar
• Gauley J., Pisetsky D. S.. The translocation of HMGB1 during cell activation and cell death. Autoimmunity. 2009; 42:299–301.
   PubMed Web of Science ®Google Scholar
• Gaipl U. S.. Waste: An important immune modulator. Autoimmunity. 2009; 42:250.
   PubMed Web of Science ®Google Scholar
• Raucci A., Palumbo R., Bianchi M. E.. HMGB1: A signal of necrosis. Autoimmunity. 2007; 40:285–289.
   PubMed Web of Science ®Google Scholar
• Hayakawa, K., L. D. Pham, Z. S. Katusic, K. Arai, and E. H. Lo. 2012. Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery, Proc Natl Acad Sci USA 7505–7510.
   Google Scholar
• LeRoy E. C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T. A.Jr, Rowell N., Wollheim F.. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 1988; 15:202–205.
   PubMed Web of Science ®Google Scholar
• LeRoy E. C., Medsger T. A.Jr. Criteria for the classification of early systemic sclerosis. J. Rheumatol. 2001; 28:1573–1576.
   PubMed Web of Science ®Google Scholar
• Guiducci S., Distler J. H., Jungel A., Huscher D., Huber L. C., Michel B. A., Gay R. E., Pisetsky D. S., Gay S., Matucci-Cerinic M., Distler O.. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum. 2008; 58:2845–2853.
   PubMed Web of Science ®Google Scholar
• Rauch U., Bonderman D., Bohrmann B., Badimon J. J., Himber J., Riederer M. A., Nemerson Y.. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood. 2000; 96:170–175.
   PubMed Web of Science ®Google Scholar
• Pendergrass S. A., Hayes E., Farina G., Lemaire R., Farber H. W., Whitfield M. L., Lafyatis R.. Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. PLoS One. 2010; 5:e12106.
   PubMed Web of Science ®Google Scholar